Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Tryozi
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict76/ 100
Grade C · #68Tryozi
A Florida telehealth that names all four of its compounding pharmacies and now sells brand-name Ozempic and Zepbound alongside compounded injections, but leads with a half-price first month.
Visit TryoziThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 76/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Tryozi still earns its place — buyers who want the compounding pharmacy named outright and a price that does not climb as the dose escalates.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results70
92
Real-world results70
97Price honesty84
97
Price honesty84
96Prescriber access78
96
Prescriber access78
88Formulary choice82
88
Formulary choice82
95Cancellation fairness70
95
Cancellation fairness70
93Member support72
93
Member support72
Price, coverage & features
| Metric | CoreAge Rx | Tryozi |
|---|---|---|
| Verdict Score | 94/100 | 76/100 |
| Grade | A | C |
| Semaglutide | $149/mo | $279/mo |
| Tirzepatide | $349/mo | $379/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Tryozi
What we like
- Names all four 503A compounding pharmacies in the footer: RedRock, Health Warehouse, Precision Medicine and Triad Rx
- Brand-name Ozempic at $1,299/mo and Zepbound at $1,399/mo are sold alongside the compounded tiers
- States in writing that 'your monthly price doesn't jump as your dose increases'
- Both the discounted first-month figure and the ongoing rate are printed together on the pricing card, before any intake
- Available in all 50 states plus D.C., with eligibility checked free and without an account
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, efficacy or manufacturing consistency
- The $139 and $189 headline figures are a 50% first-month offer only; the ongoing rates are $279 and $379
- Multi-week plans (12/24/52-week, -22%/-29%/-47%) are billed once upfront, not as a lower monthly rate
- Plans ship every four weeks, so a 52-week plan is 13 shipments rather than 12 calendar months
- No refund terms are published on the pricing page, and support hours are not stated
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Buyers who want the compounding pharmacy named outright and a price that does not climb as the dose escalates.
Visit Tryozi Read the full Tryozi review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programmes closest to it, and the same shortlist for Tryozi does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.